Compound ID | 1925
Class: Beta-lactam (aminopenicillin)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Active against Gram-positive bacteria and some Enterobacteriaceae, but vulnerable to penicillinases produced by staphylococci and E. coli |
Description: | Semisynthetic penicillin, derived from 6-aminopenicillanic acid (6-APA). Oral (bacampicillin, pivampicillin) and parenteral application. Fixed combination with sulbactam available. |
Institute where first reported: | Sandoz |
Year first mentioned: | 1953 |
Highest developmental phase: | Approved by FDA in 1971 |
Development status: | Approved, off-patent |
Chemical structure(s): | |||||||||||
|
|